Acta biomaterialia

The Journal of hospital infection

[1] High Oxygen Preservation Hydrogels to Augment Cell Survival under Hypoxic Condition.

[2] Surveillance of catheter-related bloodstream infections in haemato-oncology patients: comparison of two definitions.

[3] common genetic polymorphisms within nfκb-related genes and the risk of developing invasive aspergillosis

[4] targeted drugs as maintenance therapy after autologous stem cell transplantation in patients with mantle cell lymphoma

[5] a comparison of effects of bone marrow stem cell mobilization and bone marrow mesenchymal stem cell transplantation on the recovery of function and regeneration of rat liver tissue after massive excision of liver

[6] radioimmunotherapy of b-cell non-hodgkin’s lymphoma

[7] evidence for b cell exhaustion in chronic graft-versus-host disease

[8] myeloid derived suppressor cells as therapeutic target in hematological malignancies

[9] grand challenges in stem cell treatments

[10] streptamer versus tetramer-based selection of functional cytomegalovirus-specific t cells

[11] stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives

[12] hemorrhagic cystitis requiring bladder irrigation is associated with poor mortality in hospitalized stem cell transplant patients

[13] Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

[14] Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

[15] Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

[16] The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation

[17] Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

[18] Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

[19] Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

[20] Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

[21] Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.

[22] Unmet need for hematopoietic stem cell transplantation in older adults in developing countries: Experience from a Latin American referral center.

[23] Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.

[24] Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.

[25] Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

[26] Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients.

[27] Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.

[28] [Comparison analysis of outcomes in primary light chain amyloidosis patients treated by auto peripheral blood stem cell transplantation or bortezomib plus dexamethasone].

[29] Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

[30] First Asian, Single‐Center Experience of Blastocyst Preimplantation Genetic Diagnosis with Human Leukocyte Antigen Matching in Thailand for the Prevention of Thalassemia and Subsequent Curative Hematopoietic Stem Cell Transplantation of Ten Affected Siblings

[31] Preimplantation HLA typing for stem cell transplantation treatment of hemoglobinopathies

[32] Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.

[33] Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: A consensus process by an EBMT/ELN international working group

[34] The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.

[35] Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.

[36] Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

[37] Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.

[38] Counseling for pediatric patients undergoing hematopoietic stem cell transplantation and their parents: A pilot descriptive study.

[39] Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study.

[40] Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT).

[41] The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis.

[42] Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

[43] Psychometric properties of the Activities Ccale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium.

[44] Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.

[45] Neural Stem Cell Transplantation for Neurodegenerative Diseases

[46] High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

[47] Acute eosinophilic pneumonia after allogeneic hematopoietic stem cell transplantation

[48] Characterization of the Cellular Immune Responses to Rhizopus oryzae With Potential Impact on Immunotherapeutic Strategies in Hematopoietic Stem Cell Transplantation

[49] Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

[50] Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review

[51] A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation

[52] Autologous stem cell transplantation improves microcirculation in systemic sclerosis

[53] Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy

[54] Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period

[55] Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation

[56] understanding population-wide haplotype frequencies of human leukocyte antigen (hla) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantation

[57] clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in korea

[58] hematopoietic stem cell transplantation for the treatment of leukocyte adhesion deficiency type iii

[59] circulating cd3+cd4+cd161+ cells are associated with early complications after autologous stem cell transplantation in multiple myeloma

[60] testes de função pulmonar e mortalidade após o transplante de células-tronco hematopoiéticas hematopoietic stem cell transplantation: pulmonary function tests and post-transplant mortality

[61] targeted drugs as maintenance therapy after autologous stem cell transplantation in patients with mantle cell lymphoma

[62] reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in hodgkin lymphoma patients

[63] a comparison of effects of bone marrow stem cell mobilization and bone marrow mesenchymal stem cell transplantation on the recovery of function and regeneration of rat liver tissue after massive excision of liver

[64] long-term outcome after autologous stem cell transplantation with adequate peripheral blood stem cell mobilization using plerixafor and g-csf in poor mobilizer lymphoma and myeloma patients

[65] chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report polirradiculoneuropatia desmielinizante inflamatória crônica na doença do enxerto contra o hospedeiro após transplante de células hematopoiéticas alogênicas: relato de caso

[66] stem cell transplantation for systemic sclerosis: many steps forward in poland

[67] the role of allogeneic stem cell transplantation in relapsed/refractory hodgkin's lymphoma patients

[68] specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation

[69] high-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients

[70] antifungal treatment in stem cell transplantation centers in turkey

[71] interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target

[72] current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma

[73] preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation

[74] a 54-year-old woman with donor cell origin of multiple myeloma after allogeneic hematopoietic stem cell transplantation for the treatment of cml

[75] Prevention of Burn Wound Progression by Mesenchymal Stem Cell Transplantation: Deeper Insights Into Underlying Mechanisms.

[76] the influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute st-elevation myocardial infarction

[77] hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations

[78] functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation

[79] nk cell subgroups, phenotype and functions after autologous stem cell transplantation

[80] role of biomarkers as predictors of infection and death in neutropenic febrile patients after hematopoietic stem cell transplantation.

[81] early diagnosis and hematopoietic stem cell transplantation for il10r deficiency leading to very early-onset inflammatory bowel disease are essential in familial cases

[82] applications of flow cytometry to hematopoietic stem cell transplantation

[83] peripheral blood wt1 expression predicts relapse in aml patients undergoing allogeneic stem cell transplantation

[84] efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in bcr-abl-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation

[85] graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with aml

[86] treatment of multiple myeloma at clinical department of hematology, university medical centre ljubljana with autologous hematopoietic stem cell transplantation in years 2014 and 2015

[87] treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis

[88] Adverse reactions on day zero of hematopoietic stem cell transplantation: integrative review.

[89] allogeneic stem cell transplantation for thalassemia major in india

[90] toxoplasmosis presenting with a subtle maculopapular eruption in a child post hematopoietic stem cell transplantation

[91] daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation

[92] Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.

[93] Efficiency of in vivo purging with autologous stem cell transplantation and monoclonal antibody in B-cell lymphomas.

[94] Granulocyte Macrophage Colony-Stimulating Factor in 66 Patients with Myeloid or Lymphoid Neoplasms and Recipients of Hematopoietic Stem Cell Transplantation with Invasive Fungal Disease

[95] Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis

[96] Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation

[97] Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001)

[98] Immune Reconstitution Following Allogeneic Stem Cell Transplantation in HIV infected Individuals: Years of Living Danger-ously

[99] CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - Journal of Hematology & Oncology

[100] Granulocyte Macrophage Colony-Stimulating Factor in 66 Patients with Myeloid or Lymphoid Neoplasms and Recipients of Hematopoietic Stem Cell Transplantation with Invasive Fungal Disease

[101] Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center